Evidence Base for LCS. Trial evidence: NLST, NELSON, UKLS, LUSI, ITALUNG. EU Council 2022 Recommendation. Benefit-harm balance. Overdiagnosis. Cost-effectiveness
Speaker: Anna Rita Larici, Rome/IT
Moderator: Anagha P. Parkar, Bergen/NO
Event Details
Evidence Base for LCS. Trial evidence: NLST, NELSON, UKLS, LUSI, ITALUNG. EU Council 2022 Recommendation. Benefit-harm balance. Overdiagnosis. Cost-effectiveness
Speaker: Anna Rita Larici, Rome/IT
Moderator: Anagha P. Parkar, Bergen/NO
Time
(Monday) 18:00 - 19:00 CET
Location
Online
Organizer
ESTIoffice@myESTI.orgAm Gestade 1, 1010 Vienna, Austria
